Lakeshore Biopharma Co, Stock Market Value
| LSBPW Stock | 0.04 0.01 33.33% |
| Symbol | LakeShore |
LakeShore Biopharma Co, Company Valuation
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of LakeShore Biopharma. If investors know LakeShore will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about LakeShore Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of LakeShore Biopharma Co, is measured differently than its book value, which is the value of LakeShore that is recorded on the company's balance sheet. Investors also form their own opinion of LakeShore Biopharma's value that differs from its market value or its book value, called intrinsic value, which is LakeShore Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because LakeShore Biopharma's market value can be influenced by many factors that don't directly affect LakeShore Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between LakeShore Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if LakeShore Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, LakeShore Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
LakeShore Biopharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to LakeShore Biopharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of LakeShore Biopharma.
| 12/06/2022 |
| 11/25/2024 |
If you would invest 0.00 in LakeShore Biopharma on December 6, 2022 and sell it all today you would earn a total of 0.00 from holding LakeShore Biopharma Co, or generate 0.0% return on investment in LakeShore Biopharma over 720 days. LakeShore Biopharma is related to or competes with Lindblad Expeditions, Yuexiu Transport, BBB Foods, Simon Property, Saia, Verra Mobility, and ATRenew. LakeShore Biopharma is entity of United States More
LakeShore Biopharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure LakeShore Biopharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess LakeShore Biopharma Co, upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 15.98 | |||
| Information Ratio | 0.0426 | |||
| Maximum Drawdown | 103.97 | |||
| Value At Risk | (22.42) | |||
| Potential Upside | 31.95 |
LakeShore Biopharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for LakeShore Biopharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as LakeShore Biopharma's standard deviation. In reality, there are many statistical measures that can use LakeShore Biopharma historical prices to predict the future LakeShore Biopharma's volatility.| Risk Adjusted Performance | 0.0478 | |||
| Jensen Alpha | 1.67 | |||
| Total Risk Alpha | (1.97) | |||
| Sortino Ratio | 0.0486 | |||
| Treynor Ratio | (0.14) |
LakeShore Biopharma Co, Backtested Returns
LakeShore Biopharma Co, has Sharpe Ratio of -0.0647, which conveys that the firm had a -0.0647% return per unit of risk over the last 3 months. LakeShore Biopharma exposes thirty different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify LakeShore Biopharma's Downside Deviation of 15.98, risk adjusted performance of 0.0478, and Mean Deviation of 11.13 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of -6.41, which conveys a somewhat significant risk relative to the market. As returns on the market increase, returns on owning LakeShore Biopharma are expected to decrease by larger amounts. On the other hand, during market turmoil, LakeShore Biopharma is expected to outperform it. At this point, LakeShore Biopharma Co, has a negative expected return of -0.75%. Please make sure to verify LakeShore Biopharma's maximum drawdown, as well as the relationship between the skewness and day typical price , to decide if LakeShore Biopharma Co, performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.00 |
No correlation between past and present
LakeShore Biopharma Co, has no correlation between past and present. Overlapping area represents the amount of predictability between LakeShore Biopharma time series from 6th of December 2022 to 1st of December 2023 and 1st of December 2023 to 25th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of LakeShore Biopharma Co, price movement. The serial correlation of 0.0 indicates that just 0.0% of current LakeShore Biopharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 0.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
LakeShore Biopharma Co, lagged returns against current returns
Autocorrelation, which is LakeShore Biopharma stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting LakeShore Biopharma's stock expected returns. We can calculate the autocorrelation of LakeShore Biopharma returns to help us make a trade decision. For example, suppose you find that LakeShore Biopharma has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
LakeShore Biopharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If LakeShore Biopharma stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if LakeShore Biopharma stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in LakeShore Biopharma stock over time.
Current vs Lagged Prices |
| Timeline |
LakeShore Biopharma Lagged Returns
When evaluating LakeShore Biopharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of LakeShore Biopharma stock have on its future price. LakeShore Biopharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, LakeShore Biopharma autocorrelation shows the relationship between LakeShore Biopharma stock current value and its past values and can show if there is a momentum factor associated with investing in LakeShore Biopharma Co,.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for LakeShore Stock Analysis
When running LakeShore Biopharma's price analysis, check to measure LakeShore Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LakeShore Biopharma is operating at the current time. Most of LakeShore Biopharma's value examination focuses on studying past and present price action to predict the probability of LakeShore Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LakeShore Biopharma's price. Additionally, you may evaluate how the addition of LakeShore Biopharma to your portfolios can decrease your overall portfolio volatility.